Horm Metab Res 2011; 43(09): 636-641
DOI: 10.1055/s-0031-1283192
Animals
Georg Thieme Verlag KG Stuttgart · New York

Maternal Prolactin Inhibition During Lactation is Associated to Renal Dysfunction in their Adult Rat Offspring

M.A.R. F. Passos*
1   Department of Anatomy, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
M.C. F. Passos*
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
E. Oliveira
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
P. A. Trotta
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
J. F. Nogueira-Neto
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
I. T. Bonomo
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
P. C. Lisboa
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
,
E. G. de Moura
2   Department of Physiological Sciences, State University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 20. April 2011

accepted 28. Juni 2011

Publikationsdatum:
05. August 2011 (online)

Abstract

The renal function of rats whose mothers had hypoprolactinemia at the end of lactation was evaluated during development. Lactating Wistar rats were treated with bromocriptine (BRO, 1 mg twice a day, s.c.) or saline on days 19, 20, and 21 of lactation, and their male offspring were followed from weaning until 180 days old. 1 rat from each of the 12 litters/group was evaluated at 2 time points (90 and 180 days). Body and kidney weights, sodium, potassium, and creatinine were measured. Values were considered significant when p<0.05. Adult BRO-treated offspring presented higher body weight (+10%), lower relative renal weight at 90 and 180 days (−9.2% and −15.7%, respectively), glomerulosclerosis, and peritubular fibrosis. At 90 and 180 days, creatinine clearance was lower (−32% and −30%, respectively), whereas serum potassium was higher (+19% and +29%, respectively), but there were no changes in serum sodium. At 180 days, higher proteinuria (+36%) and serum creatinine levels (+20%) were detected. Our data suggest that prolactin inhibition during late lactation programs renal function damage in adult offspring that develops gradually, first affecting the creatinine clearance and potassium serum levels with further development of hyperproteinuria and higher serum creatinine, without affecting sodium. Thus, precocious weaning programs some components of the metabolic syndrome, which can be a risk factor for further development of kidney disease.

*

* Both authors contributed equally to this study and are considered joint first authors.


 
  • References

  • 1 Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet 2003; 361: 1629-1641
  • 2 Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001; 49: 460-467
  • 3 Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019-1022
  • 4 Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
  • 5 Hsu C-Y, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
  • 6 Nitta K. Possible link between metabolic syndrome and chronic kidney disease in the development of cardiovascular disease. Cardiol Res Pract 2010; 2011: 1-7
  • 7 Barker DJ. The fetal and infant origins of disease. Eur J Clin Invest 1995; 25: 457-463
  • 8 Moura EG, Lisboa PC, Passos MC. Neonatal programming of neuroimmunomodulation – role of adipocytokines and neuropeptides. Neuroimmunomodulation 2008; 15: 176-188
  • 9 WHO. Global strategy for infant and young child feeding. Geneva: World Health Organization; 2003
  • 10 WHO. The optimal duration of exclusive breastfeeding. Geneva: World Health Organization; 2002
  • 11 Harder T, Bergmann R, Kallischnigg G, Plagemann A. Duration of breastfeeding and risk of overweight: a meta-analysis. Am J Epidemiol 2005; 162: 397-403
  • 12 Woodall SM, Breier BH, Johnston BM, Gluckman PD. A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth. J Endocrinol 1996; 150: 231-242
  • 13 Tonkiss J, Trzcinska M, Galler JR, Ruiz-Opazo N. Prenatal malnutrition-induced changes in blood pressure: dissociation of stress and nonstress responses using radiotelemetry. Hypertension 1998; 32: 108-114
  • 14 Langley-Evans SC, Puillips GJ, Jackson AA. In utero exposure to maternal low protein diets induces hypertension in weanling rats, independently of maternal blood pressure changes. Clin Nutr 1994; 13: 319-324
  • 15 Lucas SSR, Zaladek Gil F, Costa Silva VL, Miraglia SM. Function and morphometric evaluation of intrauterine undernutrition on kidney development of the progeny. Braz J Med Biol Res 1991; 24: 967-970
  • 16 Almeida JR, Lacerda CAM. Maternal gestational protein-calorie restriction decreases the number of glomeruli and causes glomerular hypertrophy in adult hypertensive rats. Am J Obstet Gynecol 2005; 192: 945-951
  • 17 Bonomo IT, Lisboa PC, Passos MCF, Pazos-Moura CC, Moura EG. Prolactin inhibition in lactating rats changes leptin transfer through the milk. Horm Metab Res 2005; 37: 220-225
  • 18 Bonomo IT, Lisboa PC, Pereira AR, Passos MC, de Moura EG. Prolactin inhibition in dams during lactation programs for overweight and leptin resistance in adult offspring. J Endocrinol 2007; 192: 339-344
  • 19 Moura EG, Bonomo IT, Nogueira-Neto JF, de Oliveira E, Trevenzoli IH, Reis AM, Passos MC, Lisboa PC. Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny. J Physiol 2009; 587: 4919-4929
  • 20 Bonomo IT, Lisboa PC, Passos MC, Alves SB, Reis AM, de Moura EG. Prolactin inhibition at the end of lactation programs for a central hypothyroidism in adult rat. J Endocrinol 2008; 198: 331-337
  • 21 Marques RG, Morales MM, Petroianu A. Brazilian law for scientific use of animals. Acta Cirurg Brasil 2009; 24: 69-74
  • 22 Toste FP, de Moura EG, Lisboa PC, Fagundes AT, de Oliveira E, Passos MC. Neonatal leptin treatment programmes leptin hypothalamic resistance and intermediary metabolic parameters in adult rats. Br J Nutr 2006; 95: 830-837
  • 23 Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000; 279: E83-E87
  • 24 Passos MCF, Ramos CF, Moura EG. Short and long term effects of malnutrition in rats during lactation on the body weight of offspring. Nutr Res 2000; 20: 1605-1614
  • 25 Passos MCF, Ramos CF, Dutra SCP, Mouço T, Moura EG. Long term effects of malnutrition during lactation on the thyroid function of offspring. Horm Metab Res 2002; 34: 40-43
  • 26 Passos MCF, Vicente LL, Lisboa PC, Moura EG. Absence of anoretic effect to acute peripheral leptin treatment in adult animals whose mothers were malnourished during lactation. Horm Metab Res 2004; 36: 625-629
  • 27 Vicente LL, Moura EG, Lisboa PC, Costa AMA, Amadeu T, Mandarim-de-Lacerda CA, Passos MCF. Malnutrition during lactation is associated with higher expression of leptin receptor in pituitary of the adult offspring. Nutrition 2004; 20: 924-928
  • 28 Luo ZC, Xiao L, Nuyt AM. Mechanisms of developmental programming of the metabolic syndrome and related disorders. World J Diabetes 2010; 1: 89-98
  • 29 Langley-Evans SC, Welham SJM, Jackson AA. Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 1999; 64: 956-974
  • 30 Ots M, Troy JL, Rennke HG, Mackenzie HS, Brenner BM. Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease. Nephrol Dial Transplant 2004; 19: 337-341
  • 31 Zandi-Nejad K, Luyckx VA, Brenner BM. Adult Hypertension and Kidney Disease: The Role of Fetal Programming. Hypertension 2006; 47: 502-508
  • 32 Woods LL. Maternal nutrition and predisposition to later kidney disease. Curr Drug Targets 2007; 8: 906-913
  • 33 Nwagwu MO, Cook A, Langley-Evans SC. Evidence of progressive deterioration of renal function in rats exposed to a maternal low-protein diet in utero. Br J Nutr 2000; 83: 79-85
  • 34 Mathew AV, Okada S, Sharma K. Obesity related kidney disease. Curr Diabetes Rev 2011; 7: 41-49
  • 35 Wolf G, Ziyadeh FN. Leptin and renal fibrosis. Contrib Nephrol 2006; 151: 175-183
  • 36 Papafragkaki DK, Tolis G. Obesity and renal disease: a possible role of leptin. Hormones (Athens) 2005; 4: 90-95
  • 37 Hall JE, Brands MW, Henegar JR. Mechanisms of Hypertension and Kidney Disease in Obesity. Ann NY Acad Sci 1999; 18: 91-107
  • 38 Knight SF, Imig JD. Obesity, insulin resistance, and renal function. Microcirculation 2007; 14: 349-362
  • 39 Iglesias P, Dıez JJ. Thyroid dysfunction and kidney disease. European Journal of Endocrinology 2009; 160: 503-515